Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
COPD
Pharma
Insmed forecasts sales of Brinsupri will reach $1B in 2026
Insmed has projected sales of its newly approved respiratory disease drug Brinsupri will achieve sales of "at least" $1 billion in 2026.
Kevin Dunleavy
Feb 19, 2026 11:45am
Merck pays $10B to acquire Verona and COPD drug Ohtuvayre
Jul 9, 2025 11:25am
GSK revs up launch plans after Nucala's FDA approval in COPD
May 22, 2025 3:10pm
AZ looks to grow Airsupra's reach with new asthma data
May 19, 2025 12:15pm
AZ's Breztri set up for label expansion with 2 asthma trial wins
May 2, 2025 11:30am
Sanofi off to a promising start in launch of Dupixent for COPD
Apr 24, 2025 10:52am
